Korean consumer stocks have lagged the broader market, and HSBC believes weak domestic demand is mostly reflected in share prices, with Samyang Foods as its top pick.

Overview

This is an HSBC report providing a 2Q26 preview and earnings forecast update for Korean consumer coverage companies. The core view is that Korean domestic consumption remains sluggish, spending polarization continues, and consumer staples stocks have clearly underperformed the broader market year to date; however, this weakness is already largely reflected in share prices, allowing investors to revisit some lagging names. The report prefers companies supported by overseas revenue growth, earnings visibility, and shareholder returns.

Core views

HSBC continues to favor Samyang Foods, believing its long-term growth is the most sustainable and that the recent pullback offers a buying opportunity, with growth expectations revised up for the US, China, Japan, Indonesia, and Europe. KT&G is also favored due to roughly 10-11% shareholder returns in 2026-2028, strong export sales, and improving earnings. Orion continues to be supported by growth in markets such as China, Vietnam, and Russia, while CJ CheilJedang is supported by improvements in overseas food and Bio businesses. By contrast, Nongshim's overseas growth may come with higher costs, so Hold is maintained; Hite Jinro faces weakness in the beer industry and would become more attractive only after signs of sales recovery emerge.

Analysis framework

The report updates 2026-2028 earnings forecasts based on 1Q26 actual results and provides a 2Q26 preview for six covered stocks. Valuation mainly uses SOTP, EV/EBITDA, and P/E multiple methods, with 2026 used consistently as the valuation base year, while target prices are determined in conjunction with each company's historical trading range, business growth quality, overseas business contribution, and non-core asset discount.

Methodology notes

• Valuation methodsSOTP

  Sum-of-the-parts valuation

  For multi-business companies, core businesses, non-core assets, or overseas affiliates are valued separately and then added together to derive the target equity value.

• Valuation methodsEV/EBITDA multiple

  Enterprise value/EBITDA multiple

  A target EV/EBITDA multiple is applied to the core operating business, with the appropriateness of the multiple judged by reference to the high end, low end, or average of historical trading ranges as well as future OP CAGR.

• Valuation methodsP/E multiple

  Price-to-earnings multiple

  A target P/E multiple is used to value certain assets such as KT&G's red ginseng business and CJ CheilJedang's overseas Bio affiliates.

• Earnings forecastEstimate revision

  Earnings forecast revision

  2026-2028 OP forecasts are revised up or down based on 1Q26 actual results, country and category growth, margins, cost pressures, and the pace of overseas expansion.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Samyang Foods

  Top pick, Buy maintained

  Strengths

  Growth expectations revised up for the US, China, Japan, Indonesia, and Europe; rising contribution from overseas markets; capacity expansion enhances earnings visibility.

  Weaknesses

  The flavor mix in the Japanese market is not fully aligned with the company's key product strengths, and overseas expansion still needs to be executed successfully.

  Comparison

  Compared with Nongshim, HSBC prefers Samyang Foods because its overseas growth quality and profit elasticity are stronger.

  Risks

  Overseas demand below expectations, delays in capacity expansion, intensifying competition, and rising raw material costs.

• KT&G

  Preferred name, Buy maintained

  Strengths

  Strong tobacco export growth, about 10-11% shareholder returns in 2026-2028, improving NGP prospects, and a higher target price.

  Weaknesses

  The health functional food business is still in the recovery stage, and there is uncertainty around overseas partnerships and regulation.

  Comparison

  Compared with traditional food companies, KT&G has stronger support from earnings visibility and shareholder returns.

  Risks

  Anti-smoking regulations, declining domestic cigarette or HNB market share, intensifying competition, and risks related to overseas business and cooperation with PMI Global.

• Orion

  Buy maintained

  Strengths

  Markets such as China, Vietnam, and Russia continue to contribute growth; China 2026 sales growth forecast raised to 20%, with OPM expectations also revised up.

  Weaknesses

  Domestic growth in Korea is expected to be only about 3%, with a weak macro environment.

  Comparison

  It can still outperform industry growth in its major overseas markets, but the China consumer environment still needs monitoring.

  Risks

  Intense competition, weak consumption, failed new products, rising commodity and logistics costs, and food safety issues.

• CJ CheilJedang

  Buy maintained but target price lowered

  Strengths

  High proportion of overseas sales in the food business, and improving contract prices and margins for specialty products in the Bio business.

  Weaknesses

  2026-2028 OP forecasts lowered by about 1-4%, with weak domestic growth and ongoing cost pressures.

  Comparison

  Valuation uses 7.8x 2026e EV/EBITDA, still implying 45.3% upside.

  Risks

  Food business growth slower than expected, inability to raise prices, higher raw material prices, KRW weakness against USD, slow recovery in lysine prices, and overseas risks such as US tariffs.

• Nongshim

  Hold maintained

  Strengths

  Still has an overseas growth story, with growth expectations maintained in markets such as the US, China, Japan, Australia, and Vietnam.

  Weaknesses

  Overseas growth may come at the cost of higher marketing expenses and lower margins, and both the target multiple and target price were reduced.

  Comparison

  Compared with Samyang Foods, the profit quality of its overseas expansion is weaker, so HSBC prefers Samyang Foods.

  Risks

  Intense competition leading to OP margin deterioration, sharp increases in raw material costs, difficulty passing on cost pressures, and potential US tariffs.

• Hite Jinro

  Hold maintained

  Strengths

  The soju business is relatively stable, and recovery in domestic consumption plus normalization of marketing expenses could bring upside.

  Weaknesses

  The beer business is weak, with 2026 beer sales expected to decline 7% and OP forecasts lowered by about 5-6%.

  Comparison

  Compared with leading food and tobacco names, it lacks clear short-term recovery signals.

  Risks

  Loss of market share, increased marketing and promotional activity due to competition, weak domestic consumption, and failed new products.

Key data

• Sector relative performanceYear to date, covered consumer staples stocks are down about 4%, while the KOSPI is up about 95%Shows Korean consumer stocks have significantly underperformed the broader market.
• Aggregate OP growth of covered companies1H26 expected to grow 7% YoY, 2H26 expected to grow 21% YoYEarnings momentum is expected to be stronger in the second half.
• Samyang Foods target priceKRW1,900,000, implying 77.2% upsideTarget price raised from KRW1,800,000, Buy maintained.
• KT&G target priceKRW230,000, implying about 33% upsideTarget price raised from KRW200,000, Buy maintained.
• Orion target priceKRW170,000, implying 35.5% upsideBuy maintained.
• CJ CheilJedang target priceKRW270,000, implying 45.3% upsideTarget price lowered from KRW300,000, but Buy maintained.
• Nongshim target priceKRW370,000, implying 10.4% upsideTarget price lowered from KRW440,000, Hold maintained.
• Hite Jinro target priceKRW16,000, implying 6.5% upsideTarget price lowered from KRW18,000, Hold maintained.

Impact & implications

The report's investment implication for the Korean consumer sector is to move from simply avoiding weak domestic demand toward selecting stocks where bad news has been fully priced in and that offer overseas expansion, margin improvement, or shareholder returns. The clearest allocation direction is leading food and tobacco names with rising overseas revenue exposure, strong demand, and remaining valuation upside; caution is maintained on names whose growth requires heavy investment or whose industry recovery remains unclear.

Risks

• Korean domestic consumption recovers more slowly than expected.
• Intensifying competition puts pressure on volumes, pricing, or margins.
• Raw material, labor, logistics, and marketing costs come in higher than expected.
• Continued KRW weakness against USD affects import costs.
• Overseas business risks, including US tariffs, demand fluctuations in key markets, and execution risk.
• Food safety issues, regulatory changes, anti-smoking policies, or failed new products.

What to watch

• 2Q26 results will start to be released from early August and need to confirm whether earnings meet expectations.
• Whether Korea's monthly retail sales data and spending polarization improve.
• Progress in capacity and channel expansion driven by Samyang Foods' new China factory and sales offices in the US and Europe.
• KT&G export sales, NGP sales, and details of its 2H26 value enhancement plan.
• Whether Nongshim can achieve overseas growth without sacrificing margins.
• Whether Hite Jinro's beer sales volume, market share, and promotional expenses show signs of normalization.